Overview

Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function. Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Lypressin
Terlipressin
Criteria
Inclusion Criteria:

- Cirrhosis and ascites